STATE COMPANY FOR MARKETING DRUG MEDICAL APPLIANCES has floated a tender for Trastuzumab Emtansine. The project location is Iraq and the tender is closing on 25 Apr 2024. The tender notice number is MED/ 14/2024, while the TOT Ref Number is 99402594. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Iraq

Summary : Trastuzumab Emtansine

Deadline : 25 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99402594

Document Ref. No. : MED/ 14/2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : STATE COMPANY FOR MARKETING DRUG MEDICAL APPLIANCES
Baghdad/bab-Al madhm Ministry of Health / The State Company For Marketing Drug Medical Appliances (kimadia )/6th floor/Financial Dept. Tel.4157667, Mobil:707705419074, switchboard: 8, 7, 5, 4158401 Attn: Ahmed Sami
Iraq
Email :dg@kimadia.iq
URL :www.kimadia.iq

Tender Details

Tenders are invited for Trastuzumab Emtansine 100 Mg Powder for Concentrate for Solution for Infusion Vial 1200 and Pertuzumab 60 Mg /1 Ml+ Trastuzumab 60 Mg /1ml (600mg/600mg/10ml Vial) Solution for Sc Injection 1200.

Payment of a non-refundable fee with lump sum as follows:
a- (1.000.000)one million Iraqi Dinar of the tender that less than (1.000.000) Dollars .
b- (2.000.000)two million Iraqi Dinar for the tender that more than (1.000.000) Dinar.

A Bid Security at ratio 1%

Documents

 Tender Notice